Vistagen Therapeutics (VTGN) held its 2026 Annual Meeting of Stockholders, where shareholders elected four directors to the board. Key proposals were also approved during the meeting, reflecting standard corporate governance procedures.
Vistagen Therapeutics Shareholders Elect Directors, Approve Proposals
VTGNShareholder MeetingCorporate GovernanceBiotech SectorBoard Election
